Testing a connected care platform for kids with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new online platform that connects your child's diabetes devices (glucose monitor and insulin pump) with their healthcare team. The goal is to help doctors and nurses see your child's data in real time and provide better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is under 18 and has type 1 diabetes diagnosed at least 6 weeks ago.
- Your child uses a Dexcom or other glucose monitor that works with the Glooko app.
- Your child takes insulin through multiple daily injections or a pump that works with Glooko.
- You (the parent or guardian) must be willing to have a Glooko account and share your child's diabetes device data.
- Your child is not in foster care, not using a DIY looping system, and not in active treatment for an eating disorder or depression.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps children with type 1 diabetes get advanced diabetes technology, aiming to reduce gaps in access for families with fewer resources. It will check whether these tools are usable and helpful for diabetes care in children who meet the study needs.
This trial tests whether starting automated insulin therapy soon after diagnosis helps children and teens with type 1 diabetes control their blood sugar better. It uses a system that automatically adjusts insulin delivery based on continuous glucose monitoring.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests an app-based diabetes education program for people with type 1 diabetes. It aims to see if the app can help you manage your blood sugar levels better using insulin pens and a continuous glucose monitor.
This study tests a fun video game that connects to a continuous glucose monitor (CGM). The game helps kids newly diagnosed with type 1 diabetes learn about managing their condition in a playful way. Both the child and a parent need to join together.
Hear when a new Diabetes in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.